Deslauriers, Simon
Roy, Jean-Sébastien
Bernatsky, Sasha
Feldman, Debbie E.
Pinard, Anne Marie
Desmeules, François
Fitzcharles, Mary-Ann
Perreault, Kadija http://orcid.org/0000-0002-8608-9661
Funding for this research was provided by:
Canadian Rheumatology Association (CIORA grant)
Article History
Received: 9 December 2019
Accepted: 10 August 2020
First Online: 23 October 2020
Ethics approval and consent to participate
: Ethics approval for this study was obtained from the <i>Institut de réadaptation en déficience physique de Québec (IRDPQ)</i> Ethics Committee (#EMP-2015-449). Consent to participate was initially obtained upon enrollment in the Quebec Pain Registry and the current study did not require additional consent.
: Not applicable.
: AMP has received speaker fees from Purdue Pharma, Allergan and Paladins Labs and has served as a member of the external advisory board to Purdue Pharma and Paladin Labs. The authors declare they have no other competing interests.